MedTrace Logo

Hypomagnesemia Associated With Proton-Pump Inhibitor Use

NCT04426994 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 211672

Last updated 2020-06-11

No results posted yet for this study

Summary

Use of proton pump inhibitors has been associated with hypomagnesemia. However, various case-control or prospective studies have found conflicting results with regards to proton pump inhibitors use and development of hypomagnesemia. Our aim was to evaluate the likelihood that proton pump inhibitors contributed to severe hypomagnesemia in a retrospective cohort of patients admitted with severe hypomagenesemia. We also aimed to look for risk factors leading to development of hypomagnesemia amongst users of proton pump inhibitors

Conditions

Interventions

DRUG

proton pump inhibitor use

Patients using long term proton pump inhibitor

Sponsors & Collaborators

  • Changi General Hospital

    lead OTHER

Principal Investigators

  • Troy H Puar, MRCP · Changi General Hospital

Eligibility

Min Age
14 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-01-30
Completion
2019-09-30
FDA Drug
Yes

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04426994 on ClinicalTrials.gov